Concepedia

Mengni Guo

MG

Statistics

Publications

3

Citations

59

H-Index

3

Active since

2022

Affiliations

AdventHealth Orlando(Current)

West Cancer Center

Mengni Guo is an author at AdventHealth Orlando specializing in oncology, immune-mediated adverse events, and immunotherapy safety.

ORCID

Publications per year

2022–2022

3

Publications

3

Immune Checkpoint Inhibitor Rechallenge Safety and Efficacy in Stage IV Non-Small Cell Lung Cancer Patients After Immune-Related Adverse Events

Mengni Guo, Ari M. Vanderwalde, Yu Xinhua et al. · Clinical Lung Cancer · 2022 · 28 citations · Full text

, , +14

A Single Center Retrospective Study of the Impact of COVID-19 Infection on Immune-related Adverse Events in Cancer Patients Receiving Immune Checkpoint Inhibitors

Mengni Guo, Jieying Liu, Ruoyu Miao et al. · Journal of Immunotherapy · 2022 · 16 citations · Full text

, , +16

Primary breast diffuse large B cell lymphoma

Mengni Guo, Jieying Liu, Richard Gilmore et al. · BMJ Case Reports · 2022 · 15 citations · Full text

, , +10

1–3 of 3